Familial defective apolipoprotein B-100: A review

Lars H. Andersen, André R. Miserez, Zahid Ahmad, Rolf L. Andersen

Research output: Contribution to journalReview articlepeer-review

51 Scopus citations


Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant genetic disorder of lipid metabolism associated with hyperlipidemia and elevated risk for atherosclerosis. FDB is caused by mutations in APOB reducing the binding affinity between apolipoprotein B-100 and the low-density lipoprotein receptor. Population studies suggest that approximately 0.1% of Northern Europeans and US Caucasians carries the R3500Q variant in APOB most commonly associated with FDB; in addition, the APOB R3500 W variant is known to make a significant contribution to familial hypercholesterolemia (FH) among East Asians. However, the elevation of plasma low-density lipoprotein cholesterol observed in FDB is frequently milder than that of FH due to mutations in LDLR, and FDB is subsequently underdiagnosed according to standard FH diagnostic criteria.

Original languageEnglish (US)
Pages (from-to)1297-1302
Number of pages6
JournalJournal of Clinical Lipidology
Issue number6
StatePublished - Nov 1 2016


  • APOB
  • FDB
  • FH
  • Familial defective apolipoprotein B-100
  • Familial hypercholesterolemia
  • Hyperlipidemia
  • Lipid metabolism
  • Population genetics
  • R3500Q
  • R3500 W

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Familial defective apolipoprotein B-100: A review'. Together they form a unique fingerprint.

Cite this